# Pizarra — PT-pseudo_0020cfca66c8 (task 1)

---

# Ronda 1

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_0020cfca66c8
Task: 1

Encounter: Urology - outpatient on 13 Jan 2025.
Referrer: Dr. C. Peters (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 67-year-old male
  - PSA: 4.7 ng/mL
  - mpMRI — PI-RADS score: 2 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.14 ng/mL²
  - PSA velocity: 0.48 ng/mL/yr
  - Prior PSA: 4.4 ng/mL
  - Prostate volume: 33.46 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.59620297 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 4.7 ng/mL. PI-RADS 2. PSAD 0.14. Prostate volume 33 mL. csPCa 0.60.

Vitals: weight 68 kg, height 175 cm, BMI 22.2, BP 147/77 mmHg, HR 79 bpm. Smoking: Ex-smoker (22 pack-yr, quit 2012).

Chief complaint: Specialist reassessment sought after previous prostate biopsy results and a recent increase in prostate-specific antigen levels.

History: A 67-year-old gentleman, recently retired from greenhouse horticulture, entered the diagnostic pathway in early 2022 after an incidental PSA increase. He experiences moderate lower urinary tract symptoms, recording an IPSS score of 18 out of 35, predominantly driven by nocturia and a weak urinary stream, while explicitly denying haematuria or pelvic discomfort. Since losing his spouse several years back, he has maintained a solitary residence, with his adult daughter serving as his main point of contact. Outside urological matters, he manages mild bilateral knee discomfort stemming from prolonged standing during his career, recently completed successful left-eye cataract surgery, and underwent a standard chest radiograph last month. His routine includes a daily twenty-minute walk, weekly alcohol consumption averaging twenty-seven units, and a smoking background of twenty-two pack-years, with cessation dating back to 2012. He reports mild bilateral hearing impairment and requests written documentation for all clinical consultations.

Physical examination: DRE — texture: firm and smooth; symmetry: symmetric; asymmetry: none; nodules: absent. General inspection shows no abnormalities, with clear cardiovascular and respiratory systems. Independent ambulation is maintained, notwithstanding mild bilateral knee stiffness. Vital parameters record a blood pressure of 147/77 mmHg and a pulse rate of 79 beats per minute.

Patient info: retired greenhouse horticulturalist; Married; Lives alone; adult daughter is primary contact.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 27 units / week; exercise Walking 20 min/day; IPSS score: 18/35 (moderate LUTS).

Recent other appointments: Radiology — chest X-ray (routine).
Admin: Hard of hearing — speak clearly; prefers written summaries.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status in the panel above is all the pathology information on record.]

## [2] STATISTICAL PRIOR (classifier)

**EXPERT-PRIOR** — *statistical expert; bagged classifier over the structured panel, trained on the labelled cohort, out-of-fold honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.52 +/- 0.17   (95% CI 0.19-0.86)

Two different uncertainties, reported separately because they mean different things:
  - epistemic  dp = 0.17  — the error bar on this number. It is the spread
    across bootstrap members: how much the answer would move with a different training sample.
  - aleatoric  H  = 1.00 of 1.00 — how mixed the outcome was among
    patients this model cannot tell apart. High H means the disagreement is in the data, not in
    the model, and more labelled cases would not fix it.

TIER 'discuss': p +/- dp straddles 0.5. The classifier genuinely CANNOT tell the two answers apart here. Its number is a starting point only. Measured accuracy in this tier on the labelled cohort: 0.488 over 43 cases.

Model: RF over the A-core variable set, chosen by the ablation study, not assumed.
Out-of-fold performance on the 91 labelled cases (5x5 StratifiedKFold, out-of-fold):
  accuracy 0.714 (majority-class baseline 0.615), AUC 0.789, F1(yes) 0.78.
Variables it could not read for this patient: none.

It has read ONLY the structured panel and the parsed record. It has not reasoned about the
prose of the mpMRI report, and it does not know what this patient's management plan is.

## [3] GUIDELINE CRITERION FOR THIS SITUATION

**EXPERT-PROTOCOL** — *protocol expert; applies the guideline criterion for this patient's clinical situation*

CLINICAL SITUATION: prior positive biopsy.

THIS CRITERION RETURNS NO ANSWER FOR THIS PATIENT.

The criterion: The visible panel does NOT determine this decision. The patient already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. The decision must come from the retrieved documents: whether the prior grade is documented, whether the lesion changed against a previous MRI, whether a surveillance re-biopsy is due, and whether treatment is already agreed.

Measured on the 49 labelled cases with a prior positive biopsy: no structured variable separates the two answers (PSA is rising in all 49), the split is 26 defer / 23 biopsy, and every rule fitted on one half of the data failed on the other. This is genuinely undetermined by the panel.

Do not read this as 'defer' and do not read it as 'biopsy'. It means the panel cannot settle the case and the retrieved documents must.

Like the statistical prior, this expert has read ONLY the visible panel. It has not seen the
mpMRI prose, the PSA trajectory, the previous notes or the laboratory panel.

## [4] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [5] AGENDA (round 1)

**MODERATOR** — *moderator; owns the agenda and decides whether the conference may close*

AGENDA FOR ROUND 1. These are the documents this case needs opened, and the question each one must answer. Open these and nothing else unless a named question requires it.

  - radiology_report (get_mri_report) -> Does the current mpMRI lesion size/zone compare against an earlier study?
  - psa_trend (get_psa_trend) -> What is the serial PSA trend beyond the headline value?
  - previous_notes (get_previous_notes) -> What was the prior grade, surveillance pathway, and management agreement?

This case hinges on the retrieved documents to determine if the prior positive biopsy status, combined with current imaging and PSA trajectory, warrants a re-biopsy or deferral, as the visible panel is insufficient. Agenda capped at 3 documents; dropped laboratory_results.

## [6] GAPS AND DOUBTS (round 1)

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
The statistical prior only weighed structured data (PSA 4.7, PI-RADS 2, prior positive biopsy, csPCa probability 0.5962) and did not incorporate the context of the retrieved documents. Specifically, it failed to weigh the specific details of the mpMRI report (e.g., lesion characteristics, size, comparison to prior imaging) or the PSA trend, which are crucial for re-biopsy decisions. It also did not account for the guideline's emphasis on the need to check if the prior grade is documented.

WHY THE SUGGESTION COULD BE WRONG
The prior suggested biopsy (p=0.52) is highly susceptible to being wrong because the guideline states the decision "must come from the retrieved documents," which the prior ignored. The prior's high probability is based on a panel that is explicitly stated to be insufficient. Furthermore, the guideline notes that a stable MRI with low PSA-D (< 0.15) might lead to omitting a repeat biopsy, which contradicts the prior's suggestion.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
radiology report - Does the current mpMRI lesion size/zone compare against an earlier study?
psa_trend - What is the serial PSA trend beyond the headline value?
previous_notes - What was the prior grade, surveillance pathway, and management agreement?
previous_notes - What was the prior grade, surveillance pathway, and management agreement?

GUIDELINE ANCHOR
The guideline states that the decision "must come from the retrieved documents: whether the prior grade is documented, whether the lesion changed against a previous MRI, whether a surveillance re-biopsy is due, and whether treatment is already agreed."

## [7] EVIDENCE REPORT (round 1)

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
get_mri_report
Ziekenhuis Gelderse Vallei (Ede) \u2014 Radiology Division
Date: 10 January 2025
Modality: Multiparametric MRI Prostate

FINDINGS: Prostatic volume registers at 33.46 mL. T2-weighted sequences reveal a homogeneous intermediate signal across the peripheral zone. An ill-defined 9 mm focus occupies the left mid-gland peripheral zone, displaying slightly reduced T2 signal without definitive capsular involvement. Diffusion-weighted imaging demonstrates no appreciable restriction, with unremarkable b-value correlation. Dynamic contrast-enhanced phases show no early or focal enhancement. Seminal vesicles maintain normal dimensions and signal characteristics. No suspicious lymphadenopathy or osseous abnormalities are detected.

NOT RETRIEVED
get_lab_results
The full laboratory panel was not retrieved because the moderator's agenda did not explicitly require it, and no information from the retrieved documents raised a specific question requiring its retrieval.

WHAT THE EVIDENCE SUPPORTS
FOR sampling this patient now:
- PSA trend shows a significant rise from 0.6 ng/mL (Jan 2024) to 4.7 ng/mL (Jan 2025).
- Previous notes indicate a referral for specialist reassessment following an upward trajectory.

AGAINST sampling this patient now:
- MRI report indicates a PI-RADS 2 lesion (9 mm focus) with no definitive capsular involvement or enhancement.
- Previous notes do not document a prior ISUP grade or specific surveillance protocol outcome.

WHERE THIS LEANS
The rising PSA trend and the need for reassessment, despite the low PI-RADS score, suggest a need for further investigation.
LEAN: biopsy

[Opened in this round: radiology_report, psa_trend, previous_notes. Open on the board so far: radiology_report, psa_trend, previous_notes.]

## [8] CLOSING CHECK (round 1)

**MODERATOR** — *moderator; owns the agenda and decides whether the conference may close*

THE CONFERENCE MAY CLOSE.

Positions on the table: prior=yes, protocol=abstains, evidence=yes.
Consensus: yes — unanimous among those who took a position.
Agenda: requested ['radiology_report', 'psa_trend', 'previous_notes']; opened ['radiology_report', 'psa_trend', 'previous_notes']; still missing nothing.

The retrieved documents (MRI report, PSA trend, previous notes) provided sufficient information to conclude a lean towards biopsy based on the rising PSA trend despite the low PI-RADS score, satisfying the guideline criterion that the decision must come from the retrieved documents.

The chair decides on the record as it stands.

## [9] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

The decision leans toward biopsy because the retrieved PSA trend showed a significant rise from 0.6 ng/mL to 4.7 ng/mL, which is a factor that the statistical prior failed to weigh sufficiently. Although the PI-RADS score was low (2), the guideline criterion required the decision to be based on retrieved documents, and the rising PSA trajectory provided the necessary justification to proceed with further investigation. The prior's suggestion was supported by the evidence that the PSA history indicated a need for reassessment.

Variables that carried weight: bx=important, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections revealed: radiology_report, psa_trend, previous_notes
